Blackrock’s MoveAgain Brain-Computer Interface Is an FDA Breakthrough Device

Blackrock Neurotech has earned the FDA’s Breakthrough Device designation for its MoveAgain brain computer interface system.

The system is intended to give immobile patients the ability to control a mouse cursor, keyboard, mobile device, wheelchair or prosthetic device with their thoughts.

The MoveAgain system consists of an array implanted in the brain, which decodes intended movement from neuronal activity. The signals are then transmitted wirelessly to an external device, such as a cursor or wheelchair.

The goal of the device is to help the disabled reduce their reliance on caregivers and help them better engage with the world, the company said.